Sep 24, 2026 12:30PM
Nov 26, 2025 08:30AM
Nov 26, 2025 08:30AM
Oct 29, 2025 08:30AM
Jan 14, 2025 08:33AM
Jan 14, 2025 08:30AM
Jun 11, 2024 04:20PM Vistagen Reports Fiscal Year 2024 Financial Results and Provides Corporate Update
Apr 25, 2024 08:32AM
Apr 25, 2024 08:30AM
Feb 13, 2024 04:20PM
Nov 9, 2023 04:30PM
Sep 12, 2023 08:30AM
Sep 12, 2023 08:30AM
Sep 5, 2023 09:05AM VistaGen Therapeutics (VTGN) and Fuji Enter Exclusive Negotiations for a Potential License to Develop and Commercialize Vistagen’s PH80 in Japan
Sep 5, 2023 09:00AM
Aug 10, 2023 04:22PM
Aug 10, 2023 04:21PM
Jun 28, 2023 04:25PM
Jun 7, 2023 09:01AM
Jun 7, 2023 09:00AM
Mar 1, 2023 08:30AM VistaGen Therapeutics (VTGN) Announces Issuance of U.S. Patent for PH80 Nasal Spray for Treatment of Migraine
Mar 1, 2023 08:30AM
Feb 7, 2023 04:20PM
Feb 2, 2023 09:00AM
Dec 30, 2022 08:31AM
Dec 30, 2022 08:30AM
Dec 21, 2022 08:31AM
Dec 21, 2022 08:30AM Vistagen to Acquire Pherin Pharmaceuticals
Nov 10, 2022 04:30PM
Aug 11, 2022 04:20PM
Jun 23, 2022 04:20PM
Feb 10, 2022 04:20PM
Feb 10, 2022 04:20PM
Nov 10, 2021 04:20PM
Nov 10, 2021 04:20PM VistaGen Therapeutics Reports Fiscal Year 2022 Second Quarter Financial Results and Provides Corporate Update
Aug 12, 2021 04:25PM
Jun 29, 2021 04:15PM
Jun 29, 2021 04:15PM
Feb 18, 2021 09:23AM
Feb 11, 2021 04:30PM
Feb 11, 2021 04:30PM
Nov 12, 2020 05:25PM VistaGen Therapeutics Reports Fiscal 2021 Second Quarter Financial Results and Provides Highlights on its CNS Pipeline and Business Progress
Jun 29, 2020 05:16PM
Feb 13, 2020 04:30PM
Nov 7, 2019 06:30AM
Jun 25, 2019 04:15PM
Feb 12, 2019 04:49PM
Feb 12, 2019 04:49PM
Oct 29, 2018 04:30PM VistaGen Therapeutics Reports Fiscal 2019 Second Quarter Financial Results
Oct 29, 2018 04:30PM

1,202,351 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All